SXTC
China SXT Pharmaceuticals·NASDAQ
--
--(--)
--
--(--)
5.28 / 10
Netural
Analysis shows mixed fundamental quality: interest coverage ratio (42.48) and revenue-MV (-0.257) are favorable, while days sales outstanding (306.75) is a concern, placing the stock in performance group 2 with a quality score of 1/3. Revenue growth is negative YoY (-9.73%), and other factors like profit-MV (0.463) and asset-MV (-0.501) contribute to an average profile. Investment recommendation is moderate due to these conflicting metrics.
Analysis Checks(9/10)
Revenue-MV
Value-0.26
Score3/3
Weight17.30%
1M Return10.54%
Value-0.26
Score3/3
Weight17.30%
1M Return10.54%
Days sales outstanding
Value306.75
Score1/3
Weight-1.90%
1M Return-1.57%
Value306.75
Score1/3
Weight-1.90%
1M Return-1.57%
Net income-Revenue
Value-0.17
Score2/3
Weight13.81%
1M Return8.45%
Value-0.17
Score2/3
Weight13.81%
1M Return8.45%
Interest coverage ratio (EBIT / Interest expense) (%)
Value42.48
Score2/3
Weight-1.38%
1M Return-1.11%
Value42.48
Score2/3
Weight-1.38%
1M Return-1.11%
Asset-MV
Value-0.50
Score3/3
Weight25.57%
1M Return13.15%
Value-0.50
Score3/3
Weight25.57%
1M Return13.15%
Total operating revenue (YoY growth rate %)
Value-9.73
Score2/3
Weight1.48%
1M Return1.11%
Value-9.73
Score2/3
Weight1.48%
1M Return1.11%
Profit-MV
Value0.46
Score2/3
Weight13.79%
1M Return8.45%
Value0.46
Score2/3
Weight13.79%
1M Return8.45%
PB-ROE
Value-0.23
Score2/3
Weight17.20%
1M Return9.14%
Value-0.23
Score2/3
Weight17.20%
1M Return9.14%
Operating revenue (YoY growth rate %)
Value-9.73
Score2/3
Weight0.57%
1M Return0.43%
Value-9.73
Score2/3
Weight0.57%
1M Return0.43%
Cash-MV
Value-0.07
Score2/3
Weight13.56%
1M Return8.41%
Value-0.07
Score2/3
Weight13.56%
1M Return8.41%
Revenue-MV
Value-0.26
Score3/3
Weight17.30%
1M Return10.54%
Value-0.26
Score3/3
Weight17.30%
1M Return10.54%
Total operating revenue (YoY growth rate %)
Value-9.73
Score2/3
Weight1.48%
1M Return1.11%
Value-9.73
Score2/3
Weight1.48%
1M Return1.11%
Days sales outstanding
Value306.75
Score1/3
Weight-1.90%
1M Return-1.57%
Value306.75
Score1/3
Weight-1.90%
1M Return-1.57%
Profit-MV
Value0.46
Score2/3
Weight13.79%
1M Return8.45%
Value0.46
Score2/3
Weight13.79%
1M Return8.45%
Net income-Revenue
Value-0.17
Score2/3
Weight13.81%
1M Return8.45%
Value-0.17
Score2/3
Weight13.81%
1M Return8.45%
PB-ROE
Value-0.23
Score2/3
Weight17.20%
1M Return9.14%
Value-0.23
Score2/3
Weight17.20%
1M Return9.14%
Interest coverage ratio (EBIT / Interest expense) (%)
Value42.48
Score2/3
Weight-1.38%
1M Return-1.11%
Value42.48
Score2/3
Weight-1.38%
1M Return-1.11%
Operating revenue (YoY growth rate %)
Value-9.73
Score2/3
Weight0.57%
1M Return0.43%
Value-9.73
Score2/3
Weight0.57%
1M Return0.43%
Asset-MV
Value-0.50
Score3/3
Weight25.57%
1M Return13.15%
Value-0.50
Score3/3
Weight25.57%
1M Return13.15%
Cash-MV
Value-0.07
Score2/3
Weight13.56%
1M Return8.41%
Value-0.07
Score2/3
Weight13.56%
1M Return8.41%
Is SXTC undervalued or overvalued?
- SXTC scores 5.28/10 on fundamentals and holds a Fair valuation at present. Backed by its -35.71% ROE, -576.72% net margin, -0.32 P/E ratio, 0.14 P/B ratio, and -16.70% earnings growth, these metrics solidify its Netural investment rating.
